How does EUnetHTA make a difference in national and regional HTA processes? Is industry seeing an evolution in interaction between HTAs and regulators? What are the EUnetHTA JA2 Recommendations (endorsed by the EUnetHTA Plenary Assembly) on sustainable European cooperation on HTA? Where are synergies between regulation, HTA, policy and reimbursement decision-making that will benefit European patients?
Come to Rome and join HTA experts, policy and reimbursement decision-makers, patients, and healthcare industry representatives in discussions on the current and next steps in implementing the strategy for the European cooperation on HTA. A great chance to learn the latest news and network with leaders in European HTA.
Ci vediamo a Roma!
